Current developments in hematology and internal oncology;AKTUELLE ENTWICKLUNGEN IN DER HAMATOLOGIE UND INTERNISTISCHEN ONKOLOGIE

Internist

Volumn 39, Issue 4, 1998, Pages 346-354

  Walshe, R ^a   Engert, A ^a   Diehl, V ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CYTOKINE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOTOXIN; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 2; MONOCLONAL ANTIBODY; NAVELBINE; RECOMBINANT ERYTHROPOIETIN; TAMOXIFEN;

ARTICLE; CANCER CHEMOTHERAPY; DEVELOPMENT; ECONOMICS; FUTUROLOGY; GERMANY; HEMATOLOGY; HUMAN; IMMUNOTHERAPY; LYMPHOMA; MEDICAL RESEARCH; ONCOLOGY; STEM CELL TRANSPLANTATION; TUMOR; BLOOD DISEASE; INTERNAL MEDICINE; NEOPLASM; PATIENT CARE; REVIEW;

HEMATOLOGIC NEOPLASMS; HUMANS; INTERNAL MEDICINE; NEOPLASMS; PATIENT CARE TEAM;

EID: 0031980140     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050180     Document Type: Article

References (21)

1. Attal M, Harousseau JL, Stoppa AM et al. (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma: Intergroupe Francais du Myelome. N Engl J Med 335:91-97
2. Bailar III JC, Gornik HL (1997) Cancer undefeated. N Engl J Med 336:1569-1574
3. Beelen DW,Graeven U, Almaagacli AH et al. (1995) Prolonged administration of interferon-α in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome. Blood 85:2981-2990
4. Bezwoda WR, Seymour L, Dansey RD (1995) High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. J Clin Oncol 13:2483-2489
5. Diehl V (1997) Konzertierte Aktion Stammzelltransplantation. Deutsches Ärzteblatt 36:A-2241
6. Diehl V, Sieber M, Rüffer U et al. (1997) BEACOPP - an intensified chemotherapy regimen in advanced Hodgkin's Disease. The German Hodgkin's Lymphoma Study Group. Ann Oncol 8:143-8
7. Engert A, Diehl V, Schnell R et al. (1997) A Phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT3-SMPT-dgA) in patients with refractory Hodgkin's lymphoma. Blood 89:403-410
8. Gianni A, Bregni M, Siena S et al. (1997) High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 336:1290-1297
9. Giralt S, Estey E, Albitar M et al. (1997) Engraftment of allogenic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graftversus-leukemia without myeloablative therapy. Blood 89:4531-4536
10. Gough A, Clapperton M, Rolando N et al. (1997) Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet 350:855-859
11. Harris NL, Jaffe ES, Stein H et al. (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392
12. International Lymphoma Study Group (ILSG) (1997) A clinical Evaluation of the International Lymphoma Study Group Classification on Non-Hodgkin's Lymphoma. Blood 89:3909-3918
13. International multicentre pooled analysis of colon cancer trials (Impact) investigators (1995). Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345:939-944
14. Kolb H, Schattenberg A, Goldmann J et al. (1995) Graft versus leukemia effect of donor lymphocyte transfusion in marrow grafted patients. Blood 86:2041-2050
15. Mayer RJ, Davis RB, Schiffer CA et al. (1994) Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331:896-903
16. Moertel C, flemig T, Macdonald J et al. (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage II colon carcinoma: A final report. Ann Intern Med 122:321-326
17. Peters WP, Ross M,Vredenburgh JJ et al. (1993) High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11:1132-1143
18. Provan D, Barlett-Pandite L, Zwicky C et al. (1996) Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is association with improved outcome after bone marrow transplantation. Blood 88:2228-2235
19. Richtlinien zur Transplantation peripherer Blutstammzellen. Erarbeitet vom Wissenschaftlichen Beirat der Bundesärztekammer unter Mitwirkung des Paul-Ehrlich-Institutes (1997). Dtsch Ärztebl 23:A-1584-A-1592
20. Riethmüller G, Schneider-Gädicke E, Schlimok G et al.(1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes C colorectal carcinoma. Lancet 343:1177-1183
21. Schmitz N, Sextro M, Hasenclever D et al. (1997) First results of a randomized trial comparing aggressive chemotherapy with high-dose therapy (HDT) and hematopoietic stem cell transplantation (HSCT) in patients with chemosensitive relapse of Hodgkin's disease (HD). Blood 90 (Supplement 1): 115a